QCM
MRVI icon

Quantinno Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Quantinno Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-67,424
Closed -$367K – 2129
2024
Q4 		$367K Sell
67,424
-269,103
-80% -$1.73M ﹤0.01% 1328
2024
Q3 		$2.8M Buy
336,527
+289,141
+610% +$2.5M 0.04% 604
2024
Q2 		$339K Buy
47,386
+7,084
+18% +$61.2K 0.01% 1120
2024
Q1 		$349K Buy
40,302
+8,866
+28% +$60K 0.01% 1043
2023
Q4 		$206K Buy
+31,436
New +$203K 0.01% 1047

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantinno Capital Management's MRVI Position: Q1 2025 in Review

Quantinno Capital Management sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 67,424 shares — an estimated $367K sold.

Quantinno Capital Management first reported a position in MRVI in Q4 2023 and held it in 5 quarters. The position peaked at $2.8M in Q3 2024. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

  • Quantinno Capital Management reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Quantinno Capital Management sold 67,424 Maravai LifeSciences shares in Q1 2025, an estimated $367K.
  • Quantinno Capital Management first reported a position in Maravai LifeSciences in Q4 2023 and held it in 5 quarters.
  • Quantinno Capital Management's Maravai LifeSciences position peaked at $2.8M in Q3 2024.
  • 184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Quantinno Capital Management's 13F filing for Q1 2025, filed 12 May 2025.